{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 0,
        "end": 5
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 76,
        "end": 97
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 137,
        "end": 154
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 157,
        "end": 160
      }
    },
    {
      "id": "T10",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 231,
        "end": 234
      }
    },
    {
      "id": "T6",
      "obj": "Disease",
      "span": {
        "begin": 51,
        "end": 58
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23739923_9",
  "text": "IFN-a production was significantly enhanced by the hypoxia -mimicking agent deferoxamine mesylate in cell lines expressing the wild-type von Hippel-Lindau ( VHL ) gene ( KU19-20 and ACHN ) compared with cells expressing the mutant VHL gene ( 786-O ) ."
}
